This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through March 4, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana (HUM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Humana (HUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brokers Suggest Investing in Humana (HUM): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Humana (HUM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Humana (HUM) Stock Moves -1.17%: What You Should Know
by Zacks Equity Research
In the latest trading session, Humana (HUM) closed at $312.59, marking a -1.17% move from the previous day.
Centene (CNC) Wins Medicaid Contract to Better Serve Michigan
by Zacks Equity Research
Centene's (CNC) Meridian secures a contract from the Michigan Department of Health and Human Services, which gives it the opportunity to better serve the health needs of the state's Medicaid members.
CI vs. HUM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CI vs. HUM: Which Stock Is the Better Value Option?
Humana's (HUM) Medicaid Business Teams Up With CPESN USA in Ohio
by Zacks Equity Research
Humana's (HUM) partnership with CPESN USA in Ohio aims to overcome barriers like limited access to healthcare services in rural and underserved communities.
Pre-Markets in Red Before Key Economic Data
by Zacks Equity Research
Pre-Markets in Red Before Key Economic Data.
Pre-Market Futures Lower Ahead of JOLTS, U.S. Auto Sales
by Mark Vickery
Markets look to start a new trading day in the red after closing lower Monday. Bond yields, gold and oil are all up.
Health Insurance Stocks Drop: Insights Into the Late Monday Fall
by Kaibalya Pravo Dey
Higher costs and lower hikes in rates can lead to lower profit growth, which concerns investors.
Humana (HUM) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Humana (HUM) concluded the recent trading session at $351.45, signifying a +1.36% move from its prior day's close.
Is It Worth Investing in Humana (HUM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Humana (HUM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Humana (HUM) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Humana (HUM) closed the most recent trading day at $347.09, moving -0.42% from the previous trading session.
Humana (HUM), DUOS Unveil Program to Improve Veterans' Health
by Zacks Equity Research
Humana (HUM) collaborates with DUOS to develop a program that aims to provide personalized care and assure the well-being of Louisiana's Veteran community, who have a HUM MA plan and suffer from chronic conditions.
Humana (HUM) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Humana (HUM) concluded the recent trading session at $347.19, signifying a -0.28% move from its prior day's close.
CI or HUM: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CI vs. HUM: Which Stock Is the Better Value Option?
Are These 3 Beaten-Down S&P 500 Members Worth a Look?
by Derek Lewis
The market has enjoyed a fantastic run in 2024, building nicely on last year???s gains. But not all have joined the party, specifically these three. Deep in the red year-to-date, are they worth a look?
Humana (HUM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Humana (HUM) closed the most recent trading day at $345.15, moving -0.53% from the previous trading session.
Humana (HUM) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the latest trading session, Humana (HUM) closed at $339.08, marking a +0.34% move from the previous day.
Humana (HUM) Inks Value-Based Deal to Offer Better Kidney Care
by Zacks Equity Research
Humana (HUM) expands ties with Strive to offer high-quality kidney care to its Medicare Advantage members and thereby, aims to increase the customer base of the relevant business line.
Cardinal Health and Humana have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cardinal Health and Humana have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Humana (HUM)
by Derek Lewis
Increased costs have been a thorn in the side of Humana, with shares facing a nasty reaction post-earnings following its latest quarterly release.
CI vs. HUM: Which Stock Is the Better Value Option?
by Zacks Equity Research
CI vs. HUM: Which Stock Is the Better Value Option?
Humana (HUM) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
In the closing of the recent trading day, Humana (HUM) stood at $350.32, denoting a -0.24% change from the preceding trading day.
Humana (HUM) Collaborates With Veda to Enhance Efficiency
by Zacks Equity Research
Humana (HUM) partners with Veda to enhance the quality of provider directories.
Is It Worth Investing in Humana (HUM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Humana (HUM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?